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Abstract
The emergence of antibiotic-resistant and multi-drug resistant bacteria presents a growing
global health issue recognized by the World Health Organization and the Centers for
Disease Control and Prevention. Infections caused by drug-resistant bacteria are
associated with longer hospital stays, higher treatments costs, and increased mortality
compared to infections caused by antibiotic-susceptible pathogens. The global increase in
antibiotic resistance is driven in part by the misuse and overuse of antibiotics in
healthcare and agriculture. Staphylococcus aureus can infect humans and animals, and
strains that are resistant to one or more antibiotics are common.
Many plant essential oils have antimicrobial properties. Essential oils (EOs) are volatile
liquids distilled from plant parts, and they contain a variety of organic compounds. Some
EOs exhibit antibacterial, antiviral, and antifungal properties. Cinnamon bark oil (CBO)
has been identified as one EO that has bacteriostatic, bactericidal, and anti-biofilm
activities at low concentrations. Exposure to traditional antimicrobial compounds can
select for resistant bacteria, although it is unclear if exposure to essential oils selects for
resistance to essential oils or conventional antimicrobials.
Building on prior experiments, I designed a study to evaluate the extent of resistance
development among S. aureus isolates exposed to CBO in vitro. Three S. aureus isolates
were serially exposed to half-minimum inhibitory concentration of CBO or penicillin in
an agar dilution antimicrobial gradient exposure system, for 10 passages over forty days.
Penicillin exposure induced greater reductions in susceptibility compared to CBO, and
for both penicillin and CBO there was evidence of cross-resistance to the other
antimicrobial. Compared to traditional antibiotics, cinnamon bark oil may exert less
selective pressure on the antimicrobial susceptibility profile of bacterial pathogens, and
therefore may provide a more sustainable option for treating and preventing infections.
CBO may have applications in healthcare and agriculture, primarily as a topical antibiotic
or antiseptic product. Replacing some antibiotics with CBO or other essential oils could
slow the development of resistance to antimicrobials in bacterial populations.

Acknowledgements
First, I would like to acknowledge each and every student that I’ve had the privilege to
work with in the Barlow lab. From the graduate students that took me in as a sophomore
desperate to learn what it means to work in a lab, to the upperclassmen that became my
role models during that first year. Later, it was the incoming students who helped with
my undergraduate honors thesis and laid so much of the foundation for this work, and
finally the new round of graduate students who I had the pleasure of going through this
experience with: Caitlin Jeffrey, Ashma Chakrawarti, and Dave Seldow. Each of you has
helped me and taught me something new along the way.
I would like to thank the University of Vermont for offering the assistantship position
that allowed me to pursue this path.
I am grateful to each of the committee members that has provided feedback and pushed
me to produce the highest possible quality of work. This includes my master’s thesis
examination committee as well as the faculty that sat on my undergraduate thesis
committee. I am grateful for the unique insight that each of you has provided along the
way. I must also give a special thanks to my advisor for both projects, John Barlow, for
providing support and insight regarding whatever career path I stray toward on a given
day, for helping me apply to two graduate programs, for being open to learning from his
students, and for refusing to answer so many of my questions so that I became better at
answering them myself.

ii

I want to thank the Burlington, VT community and the friends I have made here. Being
surrounded by a positive community has made it much easier to spend five years working
here.
Lastly, I want to thank my family for always providing support and encouragement. I am
especially grateful to my mother Sherie, who is both a best friend and a role model. We’ll
both probably be in school forever, a blessing and a curse which I am so happy to share
with her.

iii

Table of Contents

Acknowledgements .......................................................................................................................... ii
Chapter 1 .......................................................................................................................................... 1
How exposure to plant essential oils may alter the antimicrobial susceptibility profiles of bacteria:
a review ............................................................................................................................................ 1
Antimicrobial Resistance ................................................................................................................. 1
Selective Pressure of Antibiotic Use................................................................................................ 5
Experiments In vitro ...................................................................................................................... 10
Plants as Sources of Antimicrobials and Antimicrobial Activity of Essential Oils ....................... 11
Applications ................................................................................................................................... 14
Selective Pressure of Plant Essential Oils ...................................................................................... 18
Conclusion ..................................................................................................................................... 20
References ...................................................................................................................................... 21
Chapter 2 ........................................................................................................................................ 29
Serial exposure to cinnamon bark oil or penicillin differentially promotes selection for S. aureus
resistance ........................................................................................................................................ 29
Abstract .......................................................................................................................................... 30
Introduction .................................................................................................................................... 31
Materials and Methods................................................................................................................... 34
Results............................................................................................................................................ 38
Discussion ...................................................................................................................................... 40
References ...................................................................................................................................... 46
Tables and Figures ......................................................................................................................... 50
Chapter 3 ........................................................................................................................................ 53
Conclusion ..................................................................................................................................... 53
Preliminary Work........................................................................................................................... 55
Novel Findings ............................................................................................................................... 57
Mechanisms of Resistance to Essential Oils .................................................................................. 58
Suggestions for Future Experiments .............................................................................................. 60
Suggestions for Standardizing Methodology ................................................................................. 62
Toxicology and Host Impact .......................................................................................................... 64
Applications for This Work ........................................................................................................... 65
Conclusion ..................................................................................................................................... 67
iv

References:..................................................................................................................................... 68
Bibliography .................................................................................................................................. 71

v

Chapter 1
How exposure to plant essential oils may alter the antimicrobial susceptibility
profiles of bacteria: a review

Antimicrobial Resistance
The World Health Organization recognizes antimicrobial resistance (AMR) as one of the
biggest threats to global health and food security. Current antibiotic treatments are
becoming less effective for a growing number of diseases in humans and animals, leading
to longer hospital stays, increased mortality, and higher treatment costs. Resistance to
antimicrobials occurs naturally, however it can be accelerated by the misuse and overuse
of antibiotics in healthcare and agriculture (World Health Organization, 2020).
Exposure to antimicrobials provides a selective pressure for emergence of
resistant variants. Once a resistant phenotype is present in a population, the number of
resistant individuals can increase rapidly either through direct inheritance or horizontal
gene transfer (Munita & Arias, 2016). The sustained presence of antimicrobials in the
environment lends a selective advantage to resistant mutants over the wild type.
Increased resistance to a specific drug or class of drugs can often be achieved via
different mechanisms, and the ongoing development of multiple genetic changes is a
common response in bacterial populations experiencing continuous exposure to
antimicrobials. Some of these mutations may have downstream consequences including
compromised fitness in the absence of antimicrobials or altered susceptibility to other
1

classes of antimicrobials. Additional compensatory changes in the resistant variants may
accumulate, reducing the metabolic costs of antibiotic resistance pathways and fixing the
resistant strain as a member of the microbial community. Increased resistance to one
antibiotic frequently leads to cross-resistance against other drugs with similar
mechanisms or may lead to increased sensitivity to other antimicrobial compounds
(Szybalski & Bryson, 1952). Here, cross-resistance is defined as a single resistance
mechanism leading to resistance to more than one antimicrobial within or across drug
classes. In E. coli, it has been reported that the strength of cross-resistance relationships is
highly variable, but a greater increase in drug resistance can generally be expected after
exposure to drugs within the same class of antibiotics than between classes (Lázár et al.,
2014). Co-resistance is the presence of more than one resistance mechanism leading to
resistance to multiple antibiotics in the same bacterial strain.
There are three general mechanisms of antimicrobial resistance in bacterial cells:
antimicrobial modification, control of the amount of antimicrobial accumulating in the
cell, and modification of the antimicrobial’s target site (Munita & Arias, 2016, Reygaert,
2018). Antimicrobial modification is a resistance strategy in which bacterial cells
chemically inactivate the drug molecule so that it can no longer interact with its target.
Many species of bacteria can produce proteins that perform this function using various
mechanisms including hydrolysis, group transfer, and redox reactions (Wright, 2005). A
classic example of drug resistance via destruction or modification of the drug molecule is
the production of β-lactamases by bacterial cells. These enzymes render β-lactam
molecules inert by cleaving a bond in the β-lactam ring. Even as new generations of βlactams are produced, enzymes that can deactivate them quickly follow, demonstrating
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the ability of bacteria to rapidly undergo antibiotic-driven evolution (Munita & Arias,
2016).
Bacteria can also avoid some detrimental effects of antibiotics by reducing the
amount of the drug that is able to accumulate inside the cell, either through changes in
membrane permeability or the use of efflux pumps (Munita & Arias, 2016). Efflux
pumps actively pump antibiotic molecules out of the cell and can be specific to one type
of molecule or can work on a broad range of antimicrobials. Multi-drug efflux pumps are
most often encoded on chromosomal DNA and are their expression may increase as a
result of regulatory mutations, while genes encoding drug-specific pumps are generally
found on mobile genetic elements such as plasmids (Poole, 2005). One of the first known
examples of a drug-specific efflux pump was found for tetracycline resistance in E. coli.
Decreased tetracycline susceptibility has been associated with both reduced influx and
increased efflux of the antibiotic in E. coli and these changes have been associated with
Tet genes found on at least four different plasmids (Ball et al., 1980, McMurry et al.,
1980). Since the discovery of tetracycline pumps in E. coli, at least 20 additional
tetracycline-specific efflux pumps have been described in multiple species, including
Gram-positive and Gram-negative bacteria (Poole, 2005). Even when efflux proteins are
not present, the membrane serves as the first line of defense for the cell, as most drug
targets are located intracellularly or in the periplasmic space of Gram-negative
organisms. Small, hydrophilic molecules such as β-lactams and tetracyclines can enter
bacterial cells via diffusion channels (porins), and some changes in antimicrobial
susceptibility have been associated with altered porin expression or function (Munita &
Arias, 2016). For example, expression of slightly smaller porins has been associated with
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a modest increase in the minimum inhibitory concentration (MIC) of β-lactams in K.
pneumoniae (Doménech-Sánchez et al., 2003).
The last major mechanism for antimicrobial resistance is modification of the
drug’s target. This mechanism makes it harder for the antimicrobial to interact with its
cellular target either by protecting or modifying the target. Mutations in the bacterial
genes that code for the antimicrobial’s binding site or enzymatic changes to the target can
lead to a decrease in the ability of the antimicrobial to bind to the target site (Munita &
Arias, 2016). Because this type of resistance can be caused by as little as a single point
mutation, it is common and examples of resistance by target modification can be found
for nearly all classes of antibiotics. A prominent example of antibiotic resistance by drug
target modification is demonstrated by methicillin-resistant S. aureus (MRSA).
Penicillin-binding proteins (PBPs) play a key role in maintaining the structure of the cell
wall and are a target of β-lactam antibiotics. In MRSA isolates, the bacterial cells have an
acquired mobile genetic element carrying a mec gene, typically mecA, which encodes a
unique penicillin-binding protein that has a significantly lower affinity for β-lactams
compared to wild-type PBPs (Matsuhashi et al., 1986, Matuszewska et al., 2020).
Many pathogenic species of bacteria are capable of utilizing one or more of these
methods to decrease their susceptibility to antimicrobials. The focus of this review and
associated research is Staphylococcus aureus, a Gram-positive bacteria that has the
potential to cause illness in both humans and animals and has been recorded jumping
between host species (Matuszewska et al., 2020). S. aureus is routinely monitored by the
Global Antimicrobial Resistance Surveillance System (GLASS), which is organized by
the World Health Organization (GLASS, 2020). Incidences of antimicrobial resistance in
4

S. aureus are supervised by GLASS, and resistance to penicillin and other β-lactams has
been identified as a specific concern.
Selective Pressure of Antibiotic Use
Many antibiotics are derived from secondary metabolites of bacteria and fungi,
and as such have existed in nature since long before industrial production of antibiotics to
treat human and animal disease began in the 1940s (Martin & Liras, 1989, Wright, 2005,
Clardy et al. 2009, Allen et al., 2010). A handful of retrospective studies have identified
resistance genes in bacterial isolates collected before the use of antibiotics were
widespread (Smith, 1967, Hughes & Datta, 1983). Separating the impact of human
activity from the natural evolution of antimicrobials and antimicrobial resistance
mechanisms presents a challenge, and the natural evolutionary history of these pathways
demands further exploration. There is however a clear evolutionary link between the
production of antibiotics in the natural environment and the emergence of antibioticresistance genes. Genes containing directions for the synthesis of antibiotics, and
resistance and regulatory mechanisms are commonly found clustered together, and they
are often located on mobile elements of the genome (Clardy et al. 2009).
Smith (1967) reported that the prevalence of genes carrying resistance to
kanamycin and ampicillin increased after the commercial introduction of the drugs.
Reports such as this indicate that antibiotic resistance may be expedited by human
activity, especially medical, agricultural or veterinary, and industrial use of
antimicrobials. This is further supported by findings from Walson, et al. indicating that
resistance genes in human bacterial isolates are more common in areas with a higher
human population density (2001). The use of antibiotics by humans and subsequent
5

release of these compounds into the environment occurs in clinical settings as well as in
agriculture, and examples of how each of these industries affects the susceptibility of
bacterial populations to antibiotics follow.
Antibiotics are used in veterinary medicine to treat disease, and their use is also
widespread in agriculture in the absence of detectable infection. Antibiotics are used as
food additives to improve the growth rate of the animals, and they are subsequently
released into the environment in the animals’ feces due to poor absorption rates in the gut
of the animals (Sarmah et al., 2006, Chee-Sanford et al., 2009). This practice allows for
the potential release of antibiotic residues into soil and water. Additionally, low doses of
antibiotics may lead to the development of resistant bacteria in the guts of livestock.
Multiple studies analyzing manure on farms that supplement feed with antibiotics have
isolated bacteria resistant to one or more antibiotics (Hanzawa et al., 1984, Haack &
Andrews, 2000, Cotta et al., 2003). How these resistance genes may disseminate when
released into the environment is the focus of a great deal of current research. Larouche,
et al. found that applying liquid hog manure increased the concentration of multiple
antibiotic resistance genes in soil and drainage water (2020). It is currently unclear how
readily bacteria in the environment will access this reservoir of antibiotic-resistance
genes and whether it causes a direct increase in the proportion of resistant bacteria of
medical importance. Similarly, antibiotic producer species in the environment may be a
source of resistance genes emerging among pathogens (Wright, 2007).
Antimicrobial resistance also plays a role in the dairy industry. Mastitis is a
common disease in dairy cattle and places high demand on farmers in the form of
treatment costs and associated losses in milk yield (Halasa et al., 2007, Gomes &
6

Henriques, 2016). The disease is commonly caused by bacteria and treatment typically
includes the use of antibiotics. Frequent and widespread use of antibiotics for this
purpose likely plays a role in driving up rates of resistance in bacterial populations on
farms, although the route of antimicrobial administration appears to influence the
potential for resistance development among mastitis pathogens (Nobrega et al., 2018).
Surveys of the antimicrobial resistance profiles of clinical mastitis isolates are widely
available, and results vary across different geographic regions and among bacterial
species. In large Chinese dairy herds, one survey reported that 27% of all isolates were
clinically resistant to 2 or more antibiotics (Cheng et al., 2019). The same group reported
an exceptionally high rate (66%) of resistance to penicillin in S. aureus. 10 years earlier
in Finland, S. aureus resistance to penicillin was reported in 52.1% of clinical mastitis
isolates (Pitkälä et al., 2004). In Canada, a report of isolates from clinical and sub-clinical
mastitis cases found 8.8% of S. aureus isolates to be resistant to penicillin (Saini et al.,
2012). In all of these surveys, resistance to tetracycline was consistently high, especially
among E. coli and K. pneumoniae isolates. Additionally, resistance to any antibiotic was
frequently accompanied by cross-resistance to at least one additional drug.
While it is clear that antibiotic use in agriculture contributes to resistance
reservoirs in the environment, it is suspected that most resistant infections in humans
occur in hospitals (Lerminiaux & Cameron, 2019). According to the WHO, overprescribing or misusing antibiotics contribute to the development of resistance. This
could be due in part to the fact that the use of antibiotics eliminates susceptible bacteria,
therefore leaving more resources for the most resistant individuals. In a hospital setting,
where antibiotic and antiseptic use are concentrated, it is easy to see how resistant
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microbes would hold a competitive advantage. In their 2019 review on this topic,
Lerminiaux and Cameron also state that the conditions for horizontal gene transfer occur
in clinical settings, but more research is needed to fully understand the rate at which
resistance genes may be spreading this way in hospitals. In summary, there are multiple
routes to increased AMR in hospitals: through the elimination of susceptible populations
by extensive antibiotic use and subsequent expansion of resistant populations or by the
direct transfer of resistance genes into susceptible populations.
Different countries have policies in place to prevent these phenomena, but results
vary and the development of a global strategy within a meaningful timeframe seems
unlikely. This is because deaths caused by AMR pathogens are expected to exceed deaths
caused by cancer by the year 2050 (O’Neill, 2014). Unsurprisingly, pharmaceutical
companies are compounding the problem. They have been known to distribute drugs that
are no longer approved or effective in Europe and the United States to developing
countries, ensuring the global application of selective pressure by antibiotic use (Davies
& Davies, 2010). Drug companies may have historically been unwilling to report data on
the amounts of antibiotic distributed, although legislation in many countries is driving
more transparency (Davies & Davies, 2010, Food and Drug Administration, 2020).
Further compounding the issue, the pipeline for development and approval of new
antimicrobial agents is extensive and the return on investment can be relatively small.
Many pharmaceutical companies have divested from antimicrobial drug development in
favor of a better return on investment for drugs for treatment of chronic diseases (i.e. that
a patient might take for the remainder of their life), compared to new antimicrobials (i.e.
drugs that are generally used for a limited duration to treat disease). In the face of limited
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new antimicrobial development, antimicrobial stewardship is critical to preserving
efficacy, and some have suggested we have already entered a “post-antibiotic era” (CDC,
2019).
It is imperative that we find a way to reduce the amount of antibiotics being used
and therefore reduce the selective pressure that is driving the development of antibiotic
resistance. Although many associations have been identified between the introduction of
an antibiotic and a subsequent increase in the frequency of resistance to that drug or class
of drugs, the opposite is unlikely to be true. Discontinuing use of a specific class of
antibiotics has not shown a strong correlation with a decrease in the prevalence of
resistance to that drug class (Andersson & Hughes, 2010, Garcia-Migura et al., 2014).
This may be surprising given the fitness cost most often associated with the acquisition of
mutations conferring antimicrobial resistance, however additional genetic mechanisms
subsequently come into play that may offset this cost over time. In fact, compensation, or
the acquisition of subsequent mutations that offset the fitness cost of the resistance
mutation, happens most rapidly when the cost of the original mutation is high (Durão et
al., 2018). Additionally, compensation is statistically more likely in the case of
chromosomal mutations compared to reversion to wild type simply because the range of
genetic targets is much greater (Andersson & Hughes 2010, Durão et al., 2018). Both of
these scenarios help us to understand why an energetically costly antibiotic resistance
mutation may be maintained in the absence of the drug. It is also possible for mutations
which increase resistance to have other positive effects, either under antimicrobial-free
conditions or by conferring cross-resistance. In addition to considering genetic
compensation, Andersson and Hughes (2014) also argue that antibiotic-free environments
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are extremely rare, and selection for resistant phenotypes may occur at concentrations
much lower than the reported MIC. All of these factors combine to select for and
maintain bacterial populations that are resistant to one or more antibiotics.
Experiments In vitro
In vitro experiments contribute to our efforts to understand the emergence and
dissemination of antibiotic resistance genes. Such experimentation allows the scientific
community to observe how exposure to sub-lethal amounts of antimicrobials may lead to
changes in an isolate’s susceptibility to that treatment, how resistance genes can be
transferred between organisms, and whether genetic changes in susceptibility are retained
in the absence of continued exposure.
Based on the number of published studies, it is remarkably easy to induce
antibiotic-driven adaptive microevolution in bacteria in vitro. In one experiment, motile
bacteria were introduced to a growth arena containing a steadily increasing gradient of
either trimethoprim or ciprofloxacin, with areas ranging from zero to 3,000 times the wild
type MIC of the antimicrobial. In the beginning of the experiment, the bacteria grew only
in areas of low drug concentration, and once they ran out of space on the media
containing zero times the MIC, evolving lineages appeared and began to compete for
space in areas with 3-3,000 times the wild type MIC (Baym, et al., 2016). Within about
11 days, mutant lineages had developed that could survive in the presence of 3,000 times
the original MIC. Sun et al. were also able to induce up to a 256-fold increase in MIC of
multiple antibiotics using agar plates containing a gradient of the drugs and continuously
subculturing growth from the highest part of the gradient (2018). Li et al. selected for
daptomycin resistance in S. aureus by growing the bacteria in Mueller-Hinton broth with
10

daptomycin (2017). Each of these groups observed a similar pattern of steadily increasing
resistance over time when bacteria were serially exposed to increasing sub-MIC
concentrations of antimicrobials. The gradual, continuous increase in drug tolerance is
common in experiments which expose bacterial cultures to low levels of antibiotics, and
similar results have been reported using a variety of different media types.
Plants as Sources of Antimicrobials and Antimicrobial Activity of Essential Oils
There are many useful compounds derived from plants. Examples of these include
caffeine (found in many plant species, most recognized from the coffee plant, Coffea
spp.) aspirin (i.e. salicylic acid, a derivative of salicin found in the bark of willow trees in
the genus Salix, and other plants) and opiates (most famous of the non-synthetic narcotics
extracted from the opium poppy (Papaver somniferum). These plant-derived compounds
are all capable of benefitting humans when applied in the correct context and using the
correct dose. These few examples also demonstrate, when used incorrectly, plants and
their derivatives or metabolites are toxic to humans and animals. Other popular examples
of plant-derived compounds with medical applications include digitalis, used to treat
some heart diseases, from the flowering plant foxglove (Digitalis purpurea). Examples of
plant-based foods that humans can eat but are toxic to other species, such as dogs and
cats, include onions and garlic (plants in the Allium genus) and chocolate, which contains
the methylxanthines theobromine and caffeine. Natural toxins are produced by plants as a
defense mechanism. They can reduce predation by animals or infestation by insects or
microbes (WHO, 2019). Harnessing the antimicrobial compounds naturally produced by
plants could benefit human communities.
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Due to the demand for novel antibiotics, the antimicrobial activity of plant
essential oils has been a popular area of research in recent years. Natural products such as
essential oils (EOs) have been used in traditional medicine throughout much of human
history, but there are currently no approved antibiotics derived from EOs, and only a
handful of agricultural products utilizing the oils have been made commercially available.
Essential oils are secondary plant metabolites This means that they are not
required for development and reproduction in plants but are produced by the individual to
serve another purpose. These oils contain a variety of different organic compounds, many
of which exhibit antibacterial, antifungal, and/or antiviral properties. The “oils” are
hydrophobic and lipophilic, composed of a mix of organic compounds including
terpenes, terpenoids, and aromatic components. They are typically obtained by physical
extraction from plant materials, such as steam distillation or cold pressing. The relative
amounts of these components can vary based on the harvest conditions of the plant and
the oil extraction technique. This phenomenon, combined with variation between strain
types, has led to some variation in reporting of MIC values for specific oils against a
given species of bacteria (Garcia-Salinas et al., 2018). This limitation may be
circumvented by focusing research on individual components of essential oils that have
demonstrated antimicrobial properties. It is also possible, however, that the complex
nature of the oils is valuable because multiple antimicrobial mechanisms may be in play
at once. It should be noted that EO susceptibility testing is not standardized in the way
that antibiotic susceptibility testing is, and providing standardization would likely
accelerate progress and simplify communication in the field. While antimicrobial
susceptibility testing outlined by entities such as the Clinical and Laboratory Standards
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Institute are general enough to dictate the methodology for assessing the antimicrobial
activity of essential oils, there is not enough clinical data to provide resistance cut-off
values for these compounds. Further, few studies have evaluated the pharmacokinetics
and pharmacodynamics of essential oils in clinical applications. While a specific bacterial
isolate can be deemed clinically resistant to an antibiotic such as tetracycline based on
established antimicrobial susceptibility testing break points, the same cannot yet be
determined for plant essential oils. To the author’s knowledge, no evidence of intrinsic
resistance to essential oils has yet been documented in any microbe in nature, and
whether or not a clinically relevant level of resistance can be induced is still unclear. On
the other hand, it is also unclear if effective concentrations of essential oils can be
achieved following administration, and the margin between effective doses and those that
are potentially cytotoxic to the host is largely unknown.
The primary mechanism with which essential oils inhibit bacterial growth or
damage bacterial cells appears to be targeting the cell membranes. This makes sense
considering the hydrophobic nature of essential oils, as they are chemically predisposed
to interact with the phospholipid membrane of cells. Exposure to cinnamon bark oil
(Bouhdid et al., 2010) and tea tree oil (Cox et al., 2000) has been shown to lead to
potassium ion leakage in S. aureus. Peppermint oil also compromises membrane integrity
in S. aureus, leading to the leakage of vital cellular components including nucleic acids,
proteins, and ATP (Kang et al., 2019). DNA leakage has been reported in response to the
introduction of thyme, winter savory (Vaillancourt et al., 2018), and clove (Mohamed et
al., 2018) essential oils. Yang et al. reported that treatment with a subinhibitory dose of
cinnamon bark oil led to a decrease in total protein diversity and total loss of major

13

membrane proteins in K. pneumoniae (2019). Many other mechanisms for essential oils
have been cited as well, including but not limited to oxidative stress, inhibition of cellular
respiration, inhibition of cell-to-cell signaling, coagulation of cytoplasmic material,
changes in cellular morphology, and changes in intracellular pH (Hydgaard et al., 2012,
Yang et al., 2019).
Applications
Most essential oils and their individual components are considered generally safe
for use in humans and animals. Various applications for essential oils are currently being
explored. There are an array of potential clinical uses including topical application for
burns and other superficial wounds. There is also interest in finding ways to incorporate
EOs into food preservation and agriculture.
Essential oils could be particularly valuable clinically as a treatment for bacteria
in biofilms. Biofilms are composed of a community of cells which adhere to a surface
and are surrounded by an extracellular matrix. Biofilms are associated with persistent
infections and decreased susceptibility to treatment with antibiotics, as well as decreased
susceptibility to the eukaryotic immune response (Stewart & Costerton, 2001). Essential
oils show increased effectiveness against biofilm-forming pathogens in comparison to
traditional antibiotics (Kavanaugh & Ribbeck, 2012, Feng et al., 2017). Peppermint oil
can both inhibit biofilm formation in S. aureus and inactivate mature cells in biofilm at
the MIC (Kang et al., 2019). Several studies have reported that thyme oil (Szczepanski &
Lipski, 2014), as well as the oil components eugenol and citral (Apolónio et al., 2014) are
effective at preventing biofilm formation, even at concentrations below the MIC.
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Another avenue for reducing clinical antibiotic use is taking advantage of
synergism between essential oils and certain antibiotics and antiseptics. Synergism has
been reported between essential oils and the antiseptics chlorhexidine (Vaillancourt et al.,
2018) and octenidine dihydrochloride (Kwiatkowski et al., 2020). The latter study
observed this phenomenon even against methicillin-resistant S. aureus (MRSA).
Synergism has also been recorded between several EO-antibiotic pairs. Sessa et al. found
that combining erythromycin with apple mint essential oil lowered the effect dose of the
drug needed to cure infection with Chlamydia trachomatis (2015). Against S. aureus,
cinnamon bark oil has a synergistic effect when combined with both ampicillin and
chloramphenicol (El Atki et al., 2019). Using essential oils to enhance the effects of
existing antimicrobials could lower the required dose, decreasing the demand for
industrially produced antibiotics. Since antibiotics in the environment apply a selective
pressure on bacteria, reducing antibiotic use could also slow the emergence of drugresistant strains, assuming the products replacing the traditional antibiotics exert a lower
selective pressure.
Essential oils seem to remain effective regardless of the antibiotic susceptibility
profile of the isolate being treated. This makes some essential oils excellent candidates
for treating infection by drug-resistant strains of bacteria. Mohamed et al. found clove
essential oil to be an effective treatment against multi-drug resistant (MDR) clinical
isolates from cases of eye infections (2018). A more recent study analyzed the effects of
essential oils from R. abyssinicus, C. pustulatus, and D. penninervium alone and in
combination against wound-colonizing MDR isolates of various bacterial species. The
researchers reported that the essential oils had significant antimicrobial activity against
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the strains tested and did not delay wound healing as much as traditional antibiotics
(Gadisa & Usman, 2021). Similarly, Manzuoerh et al. found dill essential oil to be more
effective than mupirocin ointment for treating MRSA-infected wounds in mice (2019).
The essential oil treatment inhibited bacterial growth and promoted wound healing at
concentrations of 2% and 4%. Taken together, these studies support the topical
application of essential-oil based antibiotics for treating certain infections of the skin and
mucous membranes. The safety of essential oils and their components in vivo is currently
under investigation. It was recently reported that the oil components carvacrol,
cinnamaldehyde and thymol are less harmful to eukaryotic macrophages and
keratinocytes than the widely used antiseptic chlorhexidine (García-Salinas et al., 2018).
In the dairy industry, there are a handful of commercial products available that
utilize essential oils or their individual components as active ingredients. PHYTOMAST® (Dr. K’s Formula, Graham, NC) is an intramammary treatment for clinical
mastitis that is intended for use in organic systems because it does not contain traditional
antibiotics. PHYTO-MAST® contains essential oils derived from thyme, wintergreen,
Chinese liquorice, and ginseng. A 2013 study determined that treatment with PHYTOMAST® resulted in “a reduction of the time to clinical recovery” (i.e. time to absence of
clinical signs, Pinedo, et al.). One hundred and sixty-three cows with clinical mastitis
from a single farm were enrolled in this study, with 88 cows receiving intramammary
PHYTO-MAST and 75 cows receiving no intramammary treatment. Cases of mastitis
were caused by Staphylococcus aureus, coagulase negative staphylococci, Streptococcus
species, and Escherichia coli, with no difference in the causal organisms between
treatment groups at enrollment. There was no difference between the PHYTO-MAST
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treated cows and the controls in the bacteriological cure nor the probability of reducing
the milk somatic cell count following treatment (Pinedo et al., 2013). Intramammary
application of the product was also deemed safe for cattle, with no evidence of an
inflammatory response to the product and rapid disappearance of thymol markers in both
the tissue and in milk following treatment (McPhee at al., 2011). The makers of PHYTOMAST® therefore claim that milk from the infected quarter can once again be harvested
and put into the milk bulk tank as little as 24 hours after treatment is complete
(PhytomastTM , 2021). Further research is needed to evaluate the efficacy of the product.
Cinnatube® (ZelpharmaLtd, UK) is another intramammary infusion product, which is
intended for use at dry-off in non-lactating cows. Mullen et al. (2014) conducted a field
trial comparing the efficacy of Cinnatube, PHYTO-MAST, and Cinnatube plus PHYTOMAST to a conventional antibiotic formulation (a positive control) and no treatment (a
negative control). The outcome measures evaluated were cure of existing infections at the
end of lactation, and prevention of new infections in the next lactation. Neither of the two
essential oil products or their combined use was better than no treatment for curing
existing infections. Similarly, the effect of the essential oil products was not different
from the positive control. There was some evidence that Cinnatube is comparable to
conventional treatment and better than no treatment for preventing new infections during
the dry period, however PHYTO-MAST and PHYTO-MAST plus Cinnatube were not
different from no treatment (Mullen et al., 2014). It should be noted, however, that the
sample of cows receiving conventional treatment in this study was small, leading to a
wide confidence interval in the results. Mullen et al. acknowledged they did not achieve
their a priori sample size and the study lacked power to demonstrate differences among
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treatments. Additional studies with greater power should be performed to further evaluate
how Cinnatube or PHYTO-MAST compare to conventional dry-off approaches. While
studies of conventional mastitis treatments have evaluated the potential for selection or
emergence of antibiotic resistant mastitis pathogens (Oliver et al., 2011; Nobrega et al.,
2018), neither of the two field studies evaluating essential oil products considered the
potential for resistance development associated with mastitis treatment.
Selective Pressure of Plant Essential Oils
Given the rapid adaptive response that bacteria can have to currently available antibiotics,
preemptive consideration should be given to the selective pressure applied by potential
new therapies. Before more antimicrobials containing plant essential oils or their
individual constituents are made commercially available, we should strengthen our
understanding of how serial exposure to these compounds may affect the antibiotic
susceptibility profile of bacteria. A number of experiments have been performed to assess
how exposure to EOs effects susceptibility to traditional antibiotics, and only a handful
have assessed changes in susceptibility to the essential oils themselves. In 2007
McMahon et al. reported that serial culture of some human pathogens in a sublethal
concentration of tea tree oil led to changes in the antimicrobial susceptibility profile of
the isolates. MIC increases fell in the range of 2-4 fold for the antibiotics measured as
well as for tea tree oil itself (McMahon et al., 2007). The same group later demonstrated
that exposure to ½ MIC tea tree oil was associated with decreased susceptibility to some
antibiotics in staphylococci, and that in the absence of the EO the isolates reverted to
their original phenotypes (McMahon et al., 2008). The authors suggest a general stress
response as the mechanism of the observed changes. Since the changes in MIC were
18

transient, McMahon et al. hypothesized that the increase was due either to a general
phenotypic change in membrane structure or fluidity or a regulatory increase in the
number of multi-drug efflux pumps. This view is also supported by the complex nature of
essential oils. Given the fact that there are likely multiple active components in one type
of oil, target site modification in the bacterial cell is unlikely to provide a significant
increase in resistant to the oil.
A few years later, Hammer et al. attempted to induce resistance to tea tree oil and
its major monoterpene component terpinene-4-ol in S. aureus and E. coli and found that
exposure to ½ MIC led to an increase in resistance of 4-fold or less. The authors also
report that the presence of these compounds in culture did not alter that frequency of
resistance to traditional antibiotics, except in the case of kanamycin + tea tree oil where
the frequency of kanamycin-resistant E. coli was lower than with kanamycin alone
(Hammer et al., 2012). In all of these studies, serial exposure to tea tree essential oil
lasted only a few days, and the maximum increase in resistance to tea tree oil during that
time was 4-fold. Another 2012 article assessed the changes in antimicrobial susceptibility
of several Gram-negative species after 50 passages of exposure to oregano and cinnamon
essential oils. Again, the maximum increase in MIC of any essential oil was 4-fold.
Interestingly, the results could not be measured in E. coli because it failed to grow after
several passages on both oregano and cinnamon oil (Becerril et al., 2012). Exposure to
eugenol, which is the primary component of clove essential oil, and citral, which is a
component of essential oils harvested from the leaves and fruits of many citrus plants, did
not induce changes in susceptibility to any antibiotics tested or to the components
themselves in S. aureus or L. monocytogenes (Apolónio et al., 2014). A recent set of
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experiments by Berdejo et al. assessed the effects of sub-inhibitory doses of orange
essential oil and the oil components carvacrol, citral, and (+)-limonene oxide on S.
aureus. Both studies reported a modest increase in MIC of the essential oil and the oil
components of 2-4 fold (Berdejo et al., 2019, Berdejo et al., 2020).
To the author’s knowledge, there is no record of subinhibitory exposure to an
essential oil or essential oil component leading to increased resistance to that compound
greater than 4x the original MIC. Since changes in antibiotic MIC have been reported to
increase more than 100 or even 1,000 times within a similar timeframe, there is some
evidence that replacing some antibiotic use with the use of essential oil-derived products
may slow the development of antimicrobial resistance.
Naturally occurring resistance to a specific essential oil has not been documented
and cannot be identified based on our current understanding of these compounds. Our
knowledge of naturally occurring resistance to plant essential oils is lacking primarily
because susceptibility profiles to EOs are not standardized. Both the methodology used to
ascertain essential oil MIC values and the numeric cut-offs used to define susceptibility
and resistance for different species of bacteria have not been clearly identified in the
literature. Compiling this information and standardizing experimental techniques would
be invaluable to the field and would likely expedite the development of applicable EOderived therapies, preservatives, and antiseptic products.
Conclusion
Antimicrobial resistance is a growing and urgent global health crisis that demands
policy reform, global monitoring, and continued efforts to develop alternative
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antimicrobial and anti-virulence products. Many plant essential oils and their individual
components have demonstrated antimicrobial properties, and therefore have the potential
to serve as alternative antimicrobial products in a variety of settings. The presence of
industrially produced antibiotics in communities, in agriculture, and in the environment
all have the potential to promote increased AMR. In vitro experimentation has
demonstrated the direct link between the presence of an antibiotic in the growth
environment and increased resistance to that antibiotic, and investigations of whether this
pattern can also be observed after treatment with plant essential oils are underway. As of
yet it is unclear why a difference has been observed in the acquisition of resistance to
essential oils and antibiotics. It is possible that the bactericidal mechanism of EOs impose
a lower threshold concentration, beyond which resistance cannot be achieved. If this
concentration were achievable in vivo and safe for eukaryotic cells, essential oils could
eventually serve as a more permanent alternative to today’s antibiotics. Due to the limited
number of publications investigating the risks of prolonged exposure to essential oils, it is
also possible that the acquisition of heritable or transferable resistance is possible and has
not yet been observed. Further investigation of the activity of plant essential oils, their
bacteriostatic and bactericidal mechanisms, and the potential mechanisms of resistance to
EOs is merited and may eventually help to play a role in reducing the number of global
deaths attributed to antimicrobial resistance.
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Abstract
Aims: Plant essential oils (EOs) have demonstrated antimicrobial properties. This
experiment was designed to test whether prolonged exposure to a plant essential oil
promotes the development of resistance to antimicrobials in S. aureus.
Methods and Results: Three S. aureus isolates were serially exposed to cinnamon bark oil
(CBO) and penicillin. The isolates were cultured for 40 days on Mueller-Hinton plates
containing a gradient of each antimicrobial, and the minimum inhibitory concentration
(MIC) of each antimicrobial was measured at the beginning of the experiment and after
even-numbered passages. Penicillin exposure induced greater changes in susceptibility to
the treatment compared to CBO, and there was evidence of cross-resistance associated
with treatment by both penicillin and CBO.
Conclusions: Compared to traditional antibiotics, cinnamon bark oil may exert less
selective pressure on the antimicrobial susceptibility profile of bacterial pathogens, and
therefore may provide a more sustainable option for treating and preventing infections.
Significance and Impact of Study: Growing populations of bacterial pathogens resistant
to one or more antibiotics have led to public health challenges and a global demand for
novel antibiotics. EOs may provide a treatment option that does not promote the
development of antimicrobial resistance at the high rate of traditional antibiotics.
Keywords
Essential oils, antibiotic resistance, antimicrobials
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Introduction
Antimicrobial resistance (AMR) is recognized as one of the biggest threats to global
health and food security by the World Health Organization. Antibiotic treatments that are
currently available are becoming less effective for a growing number of diseases in
humans and animals, and this leads to longer hospital stays, increased mortality, and
higher treatment costs. Resistance to antimicrobials occurs naturally, however it can be
accelerated by the misuse and overuse of antibiotics in healthcare and agriculture (World
Health Organization, 2020).
A growing body of evidence suggests that widespread use of antibiotics in agriculture
and clinical misuse of antibiotics support the maintenance of antimicrobial resistance
gene reservoirs in the environment and in human communities. The development of new
antibiotic treatments is one way that the scientific community and the World Health
Organization hope to reduce the number of deaths caused by drug-resistant pathogens.
In light of the demand for novel antibiotics, plant essential oils have been identified
as one potential treatment option. Because of their antimicrobial properties and low
toxicity to animals, they may have clinical applications for treating infections. Essential
oils (EOs) are secondary plant metabolites that can be harvested via different distillation
techniques. They have demonstrated antibacterial, antifungal, and antiviral properties.
The mechanism of action against bacteria depends on the origin of the oil and its
chemical makeup, which can vary depending on the distillation method as well as the age
and geographic location of the plant when it was harvested. Because of the complex
compositions of these oils, there are often multiple mechanisms in play. Since EOs are
hydrophobic, they commonly interfere with membrane permeability and cause leakage of
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cellular contents (Cox et al., 2000, Bouhdid et al., 2010, Mohamed et al., 2018, Kang et
al., 2019, Yang et al., 2019). Various plant essential oils have demonstrated synergistic
effects when combined with antibiotics and antiseptics (Kwiatkowski et al., 2020). They
are also shown to be effective against multi-drug resistant (MDR) strains of bacteria
(Gadisa & Usman, 2021).
Clinical applications for essential oils, especially for the treatment of MDR
bacteria, are currently being explored. Mohamed et al. found clove essential oil to be an
effective treatment against multi-drug resistant clinical isolates from cases of eye
infections (2018). A more recent study analyzed the effects of essential oils from R.
abyssinicus, C. pustulatus, and D. penninervium alone and in combination against wound
colonizing MDR isolates of various bacterial species. The researchers reported that the
essential oils had significant antimicrobial activity against the strains tested and did not
delay wound healing as much as traditional antibiotics (Gadisa & Usman, 2021).
Similarly, Manzuoerh et al. found dill essential oil to be more effective than mupirocin
ointment at treating MRSA-infected wounds in mice (2019). The essential oil treatment
inhibited bacterial growth and promoted wound healing at concentrations of 2% and 4%.
Taken together, these studies support the topical application of essential-oil based
antibiotics for treating certain infections of the skin and mucous membranes.
There are currently no reported instances of S. aureus displaying resistance to
treatment by cinnamon bark essential oil (CBO). In vitro exposure to traditional
antibiotics can rapidly increase bacterial MIC (Baym et al., 2016, Li et al., 2017, Sun et
al., 2018). In one such experiment Baym et al. (2016) demonstrated that, in growth
media with a steadily increasing concentration of antibiotic, mutation events created
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unique lineages of bacteria. The mutants that were able to survive in the presence of
higher concentrations of antibiotics had a selective advantage over susceptible lineages
derived from the same parent strain and were more competitive for space and nutrients.
Using a similar experimental design, Sun et al. (2018) were able to induce up to a 256fold increase in minimum inhibitory concentration (MIC) of multiple antibiotics using
agar plates containing a gradient of the drugs and continuously subculturing growth from
the highest part of the gradient. Few experiments have tested whether bacteria can
develop comparable resistance to essential oils in response to low levels of the
antimicrobials in the growth environment. After applying sub-inhibitory doses of oils or
their individual components, measured changes in MIC typically fall in the range of 0-4
fold (McMahon et al., 2008, Becerril et al., 2012, Hammer et al., 2012, Berdejo et al.,
2019, Berdejo et al., 2020). A mechanism leading to this change in MIC has not been
identified. McMahon et al. (2008) hypothesized that the increase was due either to a
general phenotypic change in membrane structure or fluidity or a regulatory increase in
the number of multi-drug efflux pumps. Due to the complex nature of essential oils, they
likely contain multiple active components and have numerous cellular targets, making
drug modification or target modification models of resistance unlikely to result in
significant changes to MIC.
This project was designed to determine whether resistance to cinnamon bark oil can
be selected for in vitro via exposure to low levels of the antimicrobial. Additionally, we
aimed to draw a comparison between the selective pressures applied by an essential oil
and a traditional antibiotic in the growth environment. We hypothesized that the fold
change in minimum inhibitory concentration (MIC) of cinnamon bark oil would be lower
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than that of penicillin after ten passages of exposure to a sub-lethal level of the
antimicrobial.

Materials and Methods
Isolate Selection
Three Staphylococcus aureus isolates were selected from a library of isolates obtained
from field studies of S. aureus prevalence among dairy farms in Vermont (Mugabi et al.,
unpublished). All isolates were coagulase-positive, catalase-positive, hemolytic, grampositive cocci and confirmed S. aureus by PCR of the thermonuclease (nuc) gene, and
were strain typed by multilocus sequencing typing (Barlow et al., 2013); the three
isolates belonged to bovine associated clonal complexes (CC) 97 and 151. At the start of
the study, all three S. aureus isolates were considered susceptible to penicillin, with
minimum inhibitory concentrations below the resistant breakpoint (0.25 ug/ml) defined
by Clinical Laboratory Standards Institute (CLSI, 2018), and were negative for blaZ and
mecA genes (Barlow et al., 2013). Isolate OF-8-01 was collected from bulk tank milk of
an organic dairy farm and is strain type ST 3021 (CC97). Isolates CP14 and CP16 were
collected from mammary glands of cows with subclinical mastitis on a conventional dairy
farm and were ST151 (CC151) and ST3028 (CC97), respectively. At the beginning of the
experiment, isolates were recovered from frozen storage, grown over night on blood agar
at 37°C, and visually assessed for purity.
Starting MIC Values
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Cinnamon Bark Oil (CBO, W229105, Sigma-Aldrich, USA) was combined with an
emulsifying agent (Tween 80, P8074, Sigma-Aldrich, USA) then added to MuellerHinton agar medium (Becton Dickinson and Company, Sparks, MD, USA), which had
been sterilized and then cooled to 45-50° C, prior to pouring plates. Due to the volatile
nature of essential oils, all CBO-containing agar plates were used within two weeks of
preparation to eliminate the possibility of changes in antimicrobial concentration.
Experiments demonstrated no difference in MIC to CBO for assays conducted within two
weeks of media preparation. To prepare penicillin plates, a liquid stock of penicillin G
sodium salt (P3032, Sigma-Aldrich, USA) dissolved in molecular grade sterile water was
added to Mueller-Hinton agar that had been sterilized and cooled to 45-50°C, prior to
pouring plates.
The initial minimum inhibitory concentration (MIC) of CBO was determined for each
isolate using a two-fold agar dilution series in accordance with CLSI guidelines (CLSI,
2018), with concentrations ranging from 0.1µl/ml to 1.6 µl/ml. Starting MIC values for
penicillin were also obtained using a two-fold agar dilution series with values ranging
from 6.25 ng/ml to 0.2 µg/ml. Each experiment was performed in triplicate. The lowest
concentration of antimicrobial on which no bacterial growth was observed was deemed
the minimum inhibitory concentration.
Preparation of Antimicrobial Gradient Plates
Linear gradient plates were prepared by pouring agar in two layers. The first layer of
antimicrobial-containing agar was poured so that it formed a slant just covering the
bottom of the petri dish, then allowed to harden completely. An arrow was drawn on the
plate to mark the direction of the slant. Following this, another layer of agar containing
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no antimicrobial was poured on top of the slant until it just covered the antimicrobialcontaining slant and formed a flat horizontal surface. The gradient plates were then stored
for at least 12 hours, to allow uniform diffusion of the antimicrobial across the agar
layers. These methods are consistent with previous experiments performed by Liu et al.
(2011) and Sun et al. (2018), and result in an agar plate in which the concentration of
antimicrobial increases from approximately zero to a maximum concentration along the
marked gradient.
Serial Exposure
To begin serial exposure on antimicrobial gradient plates, a fresh stock of each isolate
grown overnight in tryptic soy broth (TSB) was retrieved and diluted to match a 0.5
McFarland turbidity standard, or a density of about 1.5 x 108 colony forming units
(CFU/ml). 100 µl of this dilution was spread across the entire surface of the antimicrobial
gradient plate using a sterile L-shaped spreader, then allowed to dry, covered, at room
temperature. Each strain was initially inoculated onto a gradient plate where the highest
concentration of antimicrobial was twice the starting MIC for that strain. For OF 8-01
and CP16 this was 0.1 µg/ml penicillin or 0.8 µl/ml CBO, and for CP 14 the starting
concentrations were 0.05 µg/ml penicillin and 0.4 µl/ml CBO. The plates were then
inverted and incubated at 37°C for four days. Triplicate parallel exposures were
performed for each isolate in the presence of penicillin and CBO.
After four days of incubation, growth on the plates was assessed before moving
the inoculum onto a new gradient plate for the next passage. If growth was confluent
across the entire antimicrobial gradient plate, bacteria at the high end of the gradient were
picked up using a sterile loop and added to sterile water until a density of 0.5 McFarland
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was reached, then 100 µl of the inoculum was spread evenly across a new gradient plate
with twice the top concentration of the previous plate. If growth was not present across
the entire gradient, isolated colonies were picked up from the area of highest
concentration of antimicrobial (the leading edge) and the resulting bacterial suspension
was used to inoculate a fresh gradient plate with the same concentration of antimicrobial
as the plate from the previous passage. This process was repeated for a total of 10 fourday passages. Following serial exposure, mutant isolates were grown on Mueller-Hinton
agar free of antimicrobials for 10 additional (recovery) passages.
Measuring Changes in Antimicrobial Susceptibility
The minimum inhibitory concentration of Cinnamon Bark Oil was measured after
passages two, four, six, eight, ten (P10), and at the end of the recovery passages (R10)
using two-fold agar dilution series. Additionally, P10 and R10 isolates exposed to CBO
were tested for evidence of cross-resistance to penicillin using a two-fold agar dilution
series. S. aureus isolates that underwent serial exposure to penicillin were also assessed
after even-numbered passages for changes in MIC and P10 and R10 mutants were tested
for evidence of cross-resistance to CBO. Agar dilution series were performed in
accordance with CLSI guidelines. The concentrations tested varied by isolate and the
ranges were informed by the antimicrobial concentration of the gradient plate that the
isolate had last grown on successfully.
Timeline
All gradient plate exposure experiments were conducted prior to March 2020.
Preliminary MIC testing of parent strains and serial exposure on antimicrobial gradient

37

plates took place in early 2020. Disruptions in laboratory work due to COVID-19 resulted
in a pause in the experiment, during which P10 isolates were frozen and stored at -20°C
in TSB. Isolates were recovered from frozen storage and underwent 10 recovery passages
on plain media in fall of 2020, and P2-R10 MIC values were collected in Spring 2021.

Results
The starting (P0) MIC of both penicillin and cinnamon bark oil varied among S. aureus
isolates. OF 8-01 and CP16 parent strains were susceptible to penicillin at a minimum
concentration of 0.05 µg/ml, and were susceptible to cinnamon bark oil at a minimum
concentration of 0.4 µl/ml. For CP14, the P0 MIC values were 0.025 µg/ml penicillin and
0.2 µl/ml CBO.
Compared to the parent strains serial exposure to penicillin (Table 1) or cinnamon
bark oil (Table 2) always resulted in decreased susceptibility to the selective agent. After
two passages exposure to cinnamon bark oil, all three replicates of all isolates exhibited a
two-fold increase compared to the parent strain’s MIC, and the MIC values remained
constant for the remaining passages (figure 1). After 10 passages on CBO, there was no
variation within or between isolates. Serial exposure to penicillin resulted in greater
changes in MIC compared to CBO. Observed changes in penicillin MIC ranged from 4 to
256-fold after the same number of passages (figure 1). Isolates exposed to penicillin
showed more variation in acquired resistance to the selective agent. In all cases following
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penicillin exposure, we observed variation in the total change in MIC among the three
parallel descendant replicates of each parental strain.
Generally, the observed changes in antimicrobial susceptibility were stable as
determined by subsequent passages on media free of antimicrobials. Six out of nine
mutant isolates maintained an increased penicillin MIC after 10 growth passages in the
absence of the drug, and eight out of nine isolates maintained an increased cinnamon bark
oil MIC after 10 passages in the absence of the EO (Table 1).
In every case, serial exposure to cinnamon bark oil resulted in an increased
tolerance to penicillin in the Passage 10 (P10) mutants. This phenotype was stable after
10 passages of growth on antimicrobial-free media, with no differences observed between
the MIC values of the isolates after passage 10 of penicillin exposure compared to the
MIC values for penicillin of the isolate after 10 passages on penicillin free medium. The
same was true for the penicillin MIC values observed for the isolates exposed to CBO.
Exposure to CBO generally produced variants with lower penicillin MIC values
compared to than the variants selected by exposure to penicillin. Isolates that were
serially exposed to penicillin also showed evidence of increased resistance to CBO, with
a 2- or 4-fold increase in CBO resistance among the variants generated after 10 passages
of penicillin exposure. These changes are comparable to the changes observed in CBO
susceptibility in isolates that were serially exposed to cinnamon bark oil over 10
passages. Changes in CBO susceptibility were also stable after 10 growth passages on
antimicrobial-free media, except in one replicate of OF8-01 where we observed a 2-fold
decrease in the CBO MIC during the recovery passages, resulting in reversion to the wild
type susceptibility to CBO after 10 passages on CBO free medium.
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After each four-day passage cultures were examined for purity and no changes
were observed in colony morphology or hemolytic patterns among the isolates serially
exposed to CBO. In contrast, after prolonged exposure to penicillin, each of the three
isolates exhibited phenotypic changes compared to the parent strain in at least one
replicate. The most common change observed was reduced hemolysis on BAP, which
was seen in 5 out of 9 P10 isolates, and some isolates also demonstrated changes in
pigmentation and reduced colony size. These changes were stable over the subsequent 10
recovery passages on antibiotic free medium.
When comparing changes in antimicrobial susceptibility over time between
treatments, units were standardized to fold change in MIC relative to the starting (P0)
value (Figure 1). For isolates serially exposed to CBO, there was no variation within or
between isolates in fold MIC change over the 40-day serial exposure. All three replicates
of the three strains exposed to cinnamon bark oil demonstrated a two-fold increase in
CBO MIC within the first two passages, and no further change was observed in passages
4-10. The rate of change in MIC of isolates exposed to penicillin was greater overall and
was sustained throughout the serial exposure experiment. Additionally, isolates exposed
to penicillin exhibited variation in the rate of acquisition of penicillin resistance within
and between isolates (Figure 1).
Discussion
The presence of antibiotics in the environment applies selective pressure to bacteria, and
this can result in the development of antibiotic-resistant and multi-drug resistant (MDR)
strains. Antibiotic-resistant strains of bacteria can spread through communities, and
evidence suggests that certain practices in human healthcare and agriculture may enable
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this spread or support reservoirs of antibiotic resistance genes in our environment (Smith
1967, Lerminiaux & Cameron 2019, GLASS 2020). The number of bacterial isolates
resistant to one or more classes of antibiotics is increasing globally, and novel
antimicrobial treatments are in high demand. We believe our experiments are the first to
compare the changing antimicrobial susceptibility profile of S. aureus isolates exposed to
sub-inhibitory concentrations of a traditional antibiotic and a plant-derived essential oil.
Plant essential oils (EOs) have received recent attention in the scientific community due
to their demonstrated antimicrobial properties. The infrequent clinical efficacy
experiments using EOs have produced encouraging results, however the real value of
emerging antibiotics can only be ascertained by considering whether they help to place
sustainable limits on the emergence of drug-resistance in bacterial populations.
S. aureus isolates used in this experiment demonstrated key differences in their
response to prolonged exposure to cinnamon bark oil compared to penicillin. Overall,
isolates serially exposed to cinnamon bark oil showed smaller increases in MIC of both
CBO and penicillin compared to isolates exposed to penicillin. CBO exposure led to a
maximum increase in CBO minimum inhibitory concentration of only 2-fold. This is
consistent with existing publications, in which the reported change in MIC of an essential
oil after serial exposure to that compound is generally 0- to 4-fold in bacteria (McMahon
et al., 2008, Becerril et al., 2012, Hammer et al., 2012). The efficacy of essential oils
may be due in part to their complex nature, as each oil may have multiple active
constituents. When used in a pure and isolated form, however, individual components
(ICs) of essential oils maintain strong antimicrobial activity, and some experiments have
also explored the selective pressure they may apply. Apolónio et al. found no induction
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of resistance in S. aureus or L. monocytogenes after serial exposure to the ICs eugenol
and citral, and noted that the serial exposure decreased the biofilm forming capabilities of
the bacteria (2014). Similarly, terpinene-4-ol, an IC of tea tree oil, did not induce
resistance in S. aureus or E. coli after sub-lethal exposure (Hammer et al., 2012). Berdejo
et al. did report decreased susceptibility to the oil components carvacrol, citral, and (+)limonene in S. aureus after 10 days of sub-inhibitory exposure, and the maximum change
observed was a 2-fold increase in MIC (2019). There are no published findings on the
selective activity of the CBO main component cinnamaldehyde, and future investigation
of this compound would be merited based on the strong antimicrobial activity of
cinnamon bark oil, even against drug-resistant strains of bacteria (El Atki et al., 2019,
Yang et al. 2019).
Overall, measured changes in Penicillin susceptibility due to sub-inhibitory
exposure were much higher than those of CBO. While modest changes of 4-fold were
sometimes observed, the maximum increase observed in penicillin MIC was over 200fold after 40 days of serial exposure to the compound. In addition to the difference in
resulting MIC values, the pattern of changing susceptibility over the course of the
experiment differed greatly between treatments. CBO exposure led to an immediate 2fold increase in MIC, followed by a plateau in all experimental replicates. In response to
penicillin exposure, MIC was more likely to continue to increase throughout all 10
passages, and the rate of increase during the first two passages was higher than that of
isolates undergoing CBO exposure. We hypothesize that changes in the isolates’
susceptibility to penicillin is due to random mutation events that supply a competitive
advantage in the presence of the antibiotic. This is supported by the variation we observe
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between replicates (Figure 1). The morphological changes observed exclusively in
response to penicillin exposure provide additional evidence that genetic changes may
underlie the observed changes in susceptibility. In at least one serial exposure replicate
from each parent isolate, changes in colony morphology such as reduced colony size,
reduced gold pigmentation, decreased growth rate and reduced hemolysis on blood agar
were observed. Similar phenotypes have been reported in S. aureus variants associated
with persistent infection, and such isolates may carry mutations in multiple metabolic
genes (Melter & Radojevič, 2010). No changes were observed in the colony morphology
of isolates exposed to cinnamon bark oil at any point in this experiment. This difference
between treatment outcomes suggests that penicillin and CBO may exert different
selective pressures on S. aureus isolates. One factor contributing to this difference could
be a difference in de novo mutation rate influenced by the presence of the treatments.
Low levels of antibiotics have been associated with an increased mutation rate in bacteria
(Durão et al., 2018) while most essential oils have demonstrated antimutagenic properties
(Bakkali et al., 2008).As a result of penicillin exposure, isolates also exhibited decreased
sensitivity to CBO in some cases. In the case of cross-resistance, changes in CBO
susceptibility were still not as large as changes in susceptibility to penicillin. The
maximum change in MIC of CBO was a 4-fold increase compared to the parent strain
after exposure to penicillin (Table 1). This occurred in only one descendent isolate, and
most changes fell in a range comparable to that induced by exposure to CBO itself, or 0to 2-fold. In published literature, reports of cross-resistance between antibiotics and
essential oils are mixed. Several studies have reported no changes in the antibiotic
susceptibility profiles of bacterial isolates exposed to essential oils or their components
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(Hammer et al., 2012, Apolónio et al., 2014). Becerril et al. (2012) found that while
cinnamon oil did not induce cross-resistance, serial exposure to oregano essential oil was
associated with increased resistance to tetracycline, minocycline, nalidixic acid,
ciprofloxacin and chloramphenicol in S. marcescens. Additionally, serial exposure to
oregano oil was associated with a decrease in ampicillin MIC of at least 8-fold in P.
mirabilis. . A few studies have also found an association between exposure to tea tree oil
(TTO) and decreased sensitivity to some antibiotics. In S. aureus, TTO exposure was
associated with decreased sensitivity to gentamicin, vancomycin, chloramphenicol,
tetracycline, trimethoprim, ampicillin, fusidic acid, and mupirocin (McMahon et al.,
2007, McMahoon et al., 2008). In our experiments, serial exposure to cinnamon bark oil
consistently led to decreased sensitivity to penicillin, and the change was stable even after
several passages in the absence of any antimicrobials (Table 2). Observed changes in
cross-resistance were modest, but the possibility of stable changes to the antimicrobial
susceptibility profile of a pathogen should be kept in mind when considering essential
oils, alone or in combination with antibiotics, for clinical use.
In most cases the recovery passages, in which P10 lineages were grown on
Mueller-Hinton agar free of antimicrobials, did not result in a reversion to the parent
strains’ antimicrobial susceptibility phenotypes. We believe that the maintenance of
increased antimicrobial resistance in the absence of the treatments suggests that the
phenotypic changes observed resulted from chromosomal mutations rather than
regulatory mechanisms. Is it unlikely that mobile genetic elements were dispersed
throughout the samples because there was no evidence of AMR-carrying mobile genetic
elements in the parent strains (Barlow et al., 2013).
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Since increased tolerance to an antimicrobial is generally accompanied by decreased
fitness under standard conditions, we offer two explanations for the observed
maintenance of altered antimicrobial susceptibility profiles in our experimental S. aureus
lineages. First, the experiment did not allow for competition between the parent and
descendent lineages. The most resistant isolates were exclusively selected for further
passages at the end of every 4-day passage. If decreased sensitivity to the treatments was
associated with decreased fitness, the lack of competition with wild-type strains allowed
the continued growth of the altered lineage, both on the antimicrobial gradient and
antimicrobial-free plates. Second, the descendent lineages with decreased antimicrobial
susceptibility may have been maintained by subsequent compensatory mutations over
time. Previous experiments have supported the theory that antibiotic stress can increase
the mutation rate in bacteria (Durão et al., 2018). This affect, when considered alongside
short generation times and the large number of potential targets for mutations affecting
AMR, demonstrates that multiple beneficial mutations (those relating to AMR directly
and those providing compensatory effects) could have accumulated over the course of
this experiment. The stepwise increases observed in penicillin resistance over time also
indicate distinct subsequent changes. This pattern is lacking in isolates exposed to
cinnamon bark oil, so it is less clear how and when the increased resistance to cinnamon
bark oil stabilized and was able to be maintained through recovery passages. The genetic
basis of resistance to cinnamon bark oil, if one exists, would be a compelling topic for
future studies.
The increase and maintenance of antibiotic-resistant bacteria worldwide has led to
a demand for novel antimicrobial treatments. Based on this fact, the scientific and
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healthcare communities should take care to prioritize treatments that limit the rate of
acquisition of antimicrobial resistance. Some plant essential oils have broad-spectrum
antimicrobial properties, and recent experiments have found them to be effective against
wound-colonizing bacteria (Manzouerh et al., 2019, Gadisa & Usman, 2021), and other
types of infectious bacteria both alone and in combination with other antimicrobials
(Sessa et al., 2015, El Atki et al., 2019, Kwiatkowski et al., 2020). Our experiments show
smaller changes in the antimicrobial susceptibility profiles of S. aureus isolates exposed
to cinnamon bark oil than those exposed to penicillin. We encourage further investigation
of the mechanism of resistance to CBO and other plants oils and the in vivo efficacy of
these compounds. Overall, we suggest that replacement of some antibiotics or antiseptics
with EO-based products could help slow the emergence of antimicrobial resistance,
thereby reducing the cost of treatment and mortality rate associated with bacterial
infections in humans and other animals.
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Tables and Figures
Table 1 Minimum inhibitory concentration of penicillin and cinnamon bark oil in S.
aureus before (Passage 0) and after (Passage 10) serial exposure to penicillin via the
gradient plate method. Recovery 10 represents MIC after subsequent 10 passages of
variant strains on Mueller-Hinton agar free of antimicrobials. A, B, and C denote parallel
lineages derived from a single parent strain.
Isolate ID
OF8-01A

Penicillin MIC (µg/ml)
Passage 0 Passage
Recovery
10
10
0.05
0.2
0.05

Cinnamon Bark Oil MIC (µl/ml)
Passage
Passage 10 Recovery 10
0
0.4
0.8
0.8

OF8-01B

0.05

3.2

3.2

0.4

0.8

0.4

OF8-01C

0.05

3.2

3.2

0.4

0.8

0.8

CP14A

0.025

0.2

0.2

0.2

0.4

0.4

CP14B

0.025

3.2

1.6

0.2

0.2

0.2

CP14C

0.025

0.8

0.8

0.2

0.8

0.8

CP16A

0.05

3.2

3.2

0.4

0.4

0.4

CP16B

0.05

12.8

12.8

0.4

0.4

0.4

CP16C

0.05

3.2

1.6

0.4

0.4

0.4
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Table 2 Minimum inhibitory concentration of penicillin and cinnamon bark oil before
(passage 0) and after (passage 10) serial exposure to cinnamon bark oil via the gradient
plate method. Recovery 10 represents MIC after subsequent 10 passages of variant strains
on Mueller-Hinton agar free of antimicrobials. D, E, and F denote parallel lineages
derived from a single parent strain.

Isolate ID

Cinnamon Bark Oil MIC (µl/ml)

Penicillin MIC (µg/ml)

Passage 0 Passage
10

Passage
0

Recovery
10

Passage 10

Recovery 10

OF8-01D

0.4

0.8

0.8

0.05

0.4

0.4

OF8-01E

0.4

0.8

0.8

0.05

0.4

0.4

OF8-01F

0.4

0.8

0.8

0.05

0.4

0.4

CP14D

0.2

0.4

0.4

0.025

0.2

0.2

CP14E

0.2

0.4

0.4

0.025

0.2

0.2

CP14F

0.2

0.4

0.4

0.025

0.2

0.2

CP16D

0.4

0.8

0.4

0.05

0.4

0.4

CP16E

0.4

0.8

0.8

0.05

0.4

0.4

CP16F

0.4

0.8

0.8

0.05

0.2

0.2
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Figure 1. Fold change in MIC of cinnamon bark oil (▲) and penicillin (■) over the
course of 10 passages of serial exposure to the antimicrobials via the gradient plate
method. Each graph represents one parent isolate, and the three parallel descendent
lineages are represented by lines with the same symbols on the same graph.
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Microevolution in S. aureus: does exposure to sub-lethal levels of cinnamon bark oil
lead to changes in antimicrobial susceptibility?
Chapter 3
Conclusion

According to the CDC, more than 35,000 deaths each year can be attributed to
infections caused by antibiotic-resistant microorganisms (CDC 2019). This number has
decreased since the organizations previous report in 2013, and this may be due to public
health strategies that have been implemented in recent years. These strategies include
early detection and containment of threatening contagious infections, controlled use and
tracking of currently available antibiotics, expansion of vaccine availability, and
encouraging safe sex and food handling behaviors in the community. Compared to
antibiotic-susceptible organisms, infections caused by antibiotic-resistant bacteria are
more expensive to treat and result in longer hospital stays, even if the infection does not
prove to be fatal (Niederman 2001).
While healthcare workers and public health officials do their part to prevent the
emergence of bacterial resistance to antibiotics currently in use, the scientific community
continues to search for new antibiotics and alternative treatments. The widespread
availability of whole-genome sequencing is making it faster and easier to identify
antibiotics produced by microbes in trace amounts, so the search for new classes of
antibiotics continues. In addition, alternative sources of antimicrobial compounds are
now gaining popularity. Antimicrobial compounds have been isolated from plants,
marine invertebrates, insects, and even venoms and skin secretions of some vertebrates.
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Technological breakthroughs such as gene editing are also of interest to researchers
searching for novel treatments for bacterial infections. Examples of topics currently being
explored include monoclonal antibody therapies, the use of CRISPR/cas9 to target
bacterial pathogenicity islands, and the delivery of nanomaterials into infected tissues
(Mantravadi et al., 2019). Overcoming the burden of widespread antimicrobial resistance
will require continued effort on both fronts: as a community we must responsibly manage
antibiotics currently in use and put effort into developing a diverse pool of novel
treatments.
Plants have been used for medicinal purposes since the time of ancient human
civilizations (Kynes, 2013). While aromatherapy utilizing fragrant plant oils has
commonly been used for spiritual purposes, anecdotal evidence suggests that some plant
compounds have the capacity to promote wound healing, preserve food, or contribute to
personal hygiene. A look into today’s scientific literature shows us that these claims are
supported by the chemical activity of these compounds. Various plant essential oils (EOs)
have now been identified as having antibacterial, antifungal, antiviral, insecticidal, and
even anticancerogenic activities (Bakkali et al., 2008). This leads to the question: what
obstacles are preventing the widespread utilization of EOs to treat infections? First, one
must consider side-effects on a human or animal host receiving this kind of treatment.
Second, the proper applications for EO-based therapies must be identified. Lastly, it must
be considered whether widespread application of essential oils would lead to increased
bacterial resistance to the compounds and subsequently reduce their value as alternative
antibiotics. The latter obstacle is the central theme of this work, and the former two
points will be assessed further in this chapter.
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Preliminary Work
Before execution of this serial exposure experiment, preliminary work was
performed using a wider selection of essential oils and S. aureus isolates. Undergraduate
work in our lab was foundational to this project. Regarding methodology, it was
determined that agar plates containing essential oils would produce the most accurate
results for MIC testing when used within two weeks of preparation. Presumably, this is
due to the volatile nature of the oils, and all agar dilution series conducted as part of this
project used plates that were less than two weeks old. In prior experiments, MIC testing
was performed on 48 S. aureus isolates using one or more essential oils including
cinnamon bark, tea tree, thyme and wintergreen (A. Davis, unpublished; plus another ref?
) Cinnamon bark oil (CBO) was selected for use in this experiment because of its low
effective dose compared to other oils and the abundance of information in the literature
concerning its broad-spectrum effectiveness against bacteria and proposed mechanisms
of action. Preliminary data showed that S. aureus isolates resistant to β-lactams were not
differentially affected by CBO (ref unpublished). β-lactam sensitive isolates were chosen
for serial exposure based on the assumption that penicillin resistance could be induced as
a positive control (proof of concept) using the gradient plate method. Additionally, our
experimental design allowed us to study changes in cross-resistance, which were
unexpected given that β-lactam resistance has not shown a previous association with EOresistance.
Our preliminary serial exposure experiment was performed in 2017-2018
(Schuettner and Barlow, 2018 https://scholarworks.uvm.edu/hcoltheses/268/) using agar
dilution plates containing uniform concentrations of the antimicrobials. Three S. aureus
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isolates were used. OF 8-01 was susceptible to penicillin and was also used in our recent
experiment (chapter 2 of this thesis). Two penicillin-resistant isolates (OF 17-33 & OF
21-05) were serially exposed to the essential oil treatments but not to penicillin. Isolates
were exposed to either CBO or tea tree oil (TTO) at a concentration of ½ MIC for 20 24hour passages. OF 8-01 was exposed to penicillin at a concentration of ½ MIC for 12 24hour passages. Exposure to penicillin led to an increase in penicillin MIC in OF 8-01
after 2-5 days of exposure, and this increase was stable for days 5-12 of exposure.
Exposure to TTO led to sporadic changes in MIC that were not maintained in subsequent
passages, and isolates exposed to CBO showed some evidence of increasing resistance
toward the end of the experiment, but the data was inconsistent between passages and
experimental replicates. This pattern supported the hypothesis that the rate of acquisition
of resistance to antimicrobials is different between isolates exposed to penicillin or
essential oils, however the data lacked power and the methodology employed did not
maximize the selective pressure applied or allow us to isolate phenotypically distinct
colonies of interest. Additionally, the length of the experiment was increased in our
recent experiment.
One advantage of our preliminary serial exposure experiment was that it included
a measure of colony forming units (CFU) that were able to survive in the presence of
each treatment. In the case of penicillin, the proportion of CFU in the original sample that
were able to survive in the presence of ½ MIC penicillin was extremely low (<1%), and
this portion of the population rapidly expanded in response to the presence of penicillin in
the media, out-competing the susceptible individuals and reaching close to 100% by the
end of the serial exposure. In two out of three isolates, exposure to TTO decreased the
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proportion of the population that was tolerant to ½ MIC. This pattern has been reported
by other groups after exposing bacteria to an essential oil, even at a sub-inhibitory level.
In one case, Becerril et al. (2012) reported that, “E. coli could not be studied because it
failed to grow after several oregano or cinnamon passages”. In the case of cinnamon bark
oil, the proportion of CFU that were able to grow in the presence of the oil was low at the
beginning of our experiment and remained low throughout the serial exposure. Again, it
should be noted that the sample sizes in this experiment were limited, and no significant
differences could be found between tolerant CFU counts based on treatment or passage
number. Taken together, these preliminary findings formed the basis for our most recent
serial exposure experiment, and motivated me to identify an alternative approach to in
vitro serial exposure.
Novel Findings
The gradient plate method of serial exposure, adapted from Sun et al. (2018)
allowed us to eliminate many of the weaknesses from our preliminary experiments. This
type of exposure applies a near constant selective pressure on the inoculum by
introducing an increasing concentration of a desired antimicrobial. This methodology
also makes it easy to identify phenotypically unique colonies of bacteria simply by
searching for isolated colonies ogrowing on the higher concentration of the marked
antimicrobial gradient. Selecting and passing the most resistant colonies for subsequent
serial exposure to gradient plates with higher concentrations effectively increasing the
selective pressure to adapt to ever-increasing concentrations of antimicrobial. By using
this methodology and increasing the length of serial exposure from 12 days to 40 days,
we were able to induce a maximum increase in penicillin MIC of 256-fold. Contrary to
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our preliminary results, we were able to increase the MIC of cinnamon bark oil 2-fold in
all replicates of all three isolates. Taken together, these results further support the
hypothesis that there is a difference between the rate of acquisition of resistance to
cinnamon bark oil and penicillin in S. aureus field isolates following in vitro exposure.
The relevance of these findings to clinical applications of essential oils needs further
experimentation.
In the present experiment, we also observed new phenotypic differences between
S. aureus colonies exposed to penicillin and CBO. After penicillin exposure, it was
common for isolates to express changes including reduced colony size, reduced
hemolysis on blood agar, slower growth rates, and changes in pigmentation. None of
these morphological changes were observed in isolates exposed to CBO compared to the
parent strains. This observed variation suggests that there is a difference in the selective
activity of sub-inhibitory levels of penicillin and CBO on S. aureus.
Mechanisms of Resistance to Essential Oils
The mechanism of antimicrobial action of essential oils varies based on the source
of the oil and the species being treated. Based on available evidence, the target is most
often the cell membrane. Treatment with essential oils has been shown to disrupt the
membranes of bacterial cells and lead to leakage of cellular components (Cox et al.,
2000, Bouhdid et al., 2010, Mohamed et al., 2018, Kang et al., 2019). If a specific
mutation leading to increased resistance were identified, it could help us understand the
cellular target in more detail. Alternatively, increased resistance could result from general
regulatory mechanisms such as decreased membrane fluidity or permeability or an
increase in the number or efficiency of multi-drug efflux pumps. It has been
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demonstrated that the presence of multi-drug efflux pumps is vital to some bacteria-plant
interactions (Blanco et al., 2016). In one example, García-León et al. (2014) showed that
the bacteria S. maltophilia is unable to colonize the roots of plants when it lacks the
SmeDEF efflux pump. This suggests that efflux pumps play a part in removing some
harmful plant-produced compounds from bacteria cells. In P. aeruginosa, the absence of
certain multi-drug efflux pumps has been associated with an increased susceptibility to
tea tree oil and combined treatment with TTO and an efflux inhibitor in wild type strains
also resulted in decreased tea tree oil MIC (Papadopoulos et al., 2008). Furthermore, it
has been suggested that efflux pumps in P. aeruginosa grant intrinsic tolerance to some
plant essential oils (Cox & Markham, 2007).
Berdejo et al. (2019, 2020) were able to produce mutant strains of S. aureus with
slightly increased resistance to orange essential oil as well as the oil components
carvacrol, citral, and (+)-limonene. After sequencing the genomes of the mutants, this
group identified some genetic changes in the derivative strains. The EO-resistant mutants
as well as the citral-resistant mutants both had similar mutations in a pathway involved in
the synthesis of vitamin K2. The authors suggest that this change would result in reduced
production and accumulation of reactive oxygen species (ROS), which could increase
survival in the presence of orange essential oil and its components. Another key change
identified in the S. aureus exposed to orange essential oil was in a fatty acid synthesis
pathway associated with the assembly of membrane phospholipids. This change confirms
common speculation that changes in membrane structure could allow for some increased
resistance to treatment by essential oils. Even though multiple mutations were identified
in the EO-resistant mutant, the increase in resistance observed was still less than 4-fold.
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This suggests that there are factors limiting the degree of resistance that can be obtained.
The essential oil may be resistant to degradation or have multiple cellular targets. There
is some evidence that plant EOs may inhibit efflux pumps as well (Chovanová et al.,
2015). This would help to explain the low rates of resistance to EOs, their activity against
multi-drug resistant bacteria, and their synergistic effects with some antibiotics. One
experiment showed that essential oils from Salvia species were synergistic with
tetracycline against S. aureus, and their presence decreased efflux of the antibiotic
(Chovanová et al., 2015).
Our understanding of the mechanisms of action of essential oils has come a long
way in recent years as the antimicrobial potential of these compounds has received
renewed attention. Understanding whether clinically significant resistance to essential
oils can be obtained will require a closer look at the mechanisms in play as well as how
these dynamics may change in vivo. Strengthening our understanding of the mechanisms
of action of and resistance to plant essential oils will allow us to find the best applications
for their use and potentially the most effective ways to utilize them in combination with
other antimicrobials.
Suggestions for Future Experiments
One way to discover the mechanisms of resistance to essential oils is to sequence
the genomes of bacteria with increased tolerance to them. Further evolution experiments
will be the key to understanding how bacteria react to the presence of EOs in the growth
environment. Isolates serially exposed to essential oils in a controlled setting are
excellent candidates for genomic and proteomic sequencing, as this will help us
understand the functional and regulatory differences in these strains compared to a
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susceptible wild type. In our experiment, samples of each isolate were frozen down after
each passage, so future experiments in our lab have the potential to focus on specific time
points during which changes in MIC took place.
Another question warranting further exploration is whether there is a difference in
the selective activity of complex essential oils and their individual constituents (ICs).
Both compounds have demonstrated antimicrobial activity, however neither are
commonly used as antibiotics or antiseptics. Here, I demonstrated that there is a
difference between the selective activity of cinnamon bark oil and penicillin on S. aureus.
I recommend repeating this serial exposure experiment using isolated cinnamaldehyde as
a treatment to assess whether its selective activity is more similar to that of CBO or
penicillin or whether it behaves uniquely. One might hypothesize that using an individual
constituent of an oil rather than a complex essential oil would reduce the number of
cellular targets, making resistance more likely to emerge. The published results on serial
exposure to ICs vary, with some reporting no change in MIC (Hammer et al., 2012,
Apolónio et al., 2014) and one report of minor (2-fold) increases in MIC and evidence of
associated genetic changes (Berdejo et al., 2019). To our knowledge, a serial exposure
experiment using cinnamaldehyde has not yet been published.
Our final suggestion for future experimentation using essential oils is the
inclusion of more in vivo trials. Suggested uses for essential oil products will be
expanded on below in the section “Applications for This Work”, and I suggest that
experiments are designed with these scenarios in mind. In order to get more EO-based
antimicrobial products to market, we must develop our understanding of the antimicrobial
and selective activity of these compounds in animal models.
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Suggestions for Standardizing Methodology
A review of literature addressing the antimicrobial activity of essential oils
exposes some inconsistencies in methods. Antibiotic susceptibility testing and resistance
cut-off values are standardized so that global communication about the topic is supported
and information is widely accessible. This information accessibility has probably aided in
the recent improvements in the management of drug-resistant infections and the decrease
in recorded deaths caused by antibiotic-resistant pathogens. In order to maximize the
efficiency and impact of studies pertaining to the antimicrobial activity of essential oils,
some standardized methodology should be implemented. Currently, guidelines for
antibiotic susceptibility testing are often adapted for applications using essential oils.
Reported methods of MIC testing for essential oils include agar dilution assays, disk
diffusion and broth or broth micro-dilution assays among others.
The most obvious problem with adapting guidelines for antibiotic susceptibility
testing is the fact that plant essential oils and their components are generally
hydrophobic, and there is variation in methods used to incorporate them into solid or
liquid media. Some evidence suggests that the use of emulsifying agents, which is
common and was part of the methodology in our experiment, can increase the dose of an
oil needed to inhibit bacterial growth (Remmal et al., 1993). Used alone, Tween 80 has
been reported to increase the growth of S. aureus compared to culture in plain media
(Nielson et al., 2016); this was observed in prior experiments in the Barlow lab (A.
Davis, unpublished). Other emulsifying agents such as DMSO are sometimes employed,
the concentration of these agents varies between experiments, and occasionally
information on the emulsification process of EOs is left out of a study’s “Materials and
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Methods” section entirely. In order to compare the results of these studies with
confidence, the methodology by which EOs are incorporated into media should be
standardized.
As we have previously stated, the volatile nature of essential oils should also be
considered when preparing oil-containing media. Based on our preliminary experiments
Mueller-Hinton agar plates containing essential oils solubilized by Tween 80 should be
used within two weeks of preparation to avoid changes in the MIC values obtained via
agar dilution series. Based on this information, we suggest that oil-containing plates used
for any other purpose (such as serial exposure) should also be used within two weeks of
preparation to maximize their effectiveness.
Lastly, if essential oils are formulated for clinical use, cut-off values for clinical
resistance to essential oil treatments should be established. In the case of antibiotics, MIC
values obtained from susceptibility testing can be correlated with qualitative values of
“resistant” or “susceptible” using data obtained from clinical treatment trials. No such
categorizations exist for plant essential oils, likely because only a small number of
clinical trials have been completed and none of these trials appeared to collect data
related to isolate susceptibility to the EO formulations.. This limits the conclusions that
can be drawn from in vitro experiments, because even when resistance to an essential oil
is increased to some degree there is no evidence that the change would affect our ability
to use that EO to treat infection in a host. Therefore, future in vivo experiments should be
prioritized to address this shortcoming, and we should begin by determining what dose of
essential oils can safely be achieved in an animal model.
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Toxicology and Host Impact
Many plant essential oils have demonstrated broad-spectrum antimicrobial
activity, and oil-containing products are often marketed as treatments for various
ailments. These products are not approved or regulated by the FDA and therefore occupy
a market niche similar to that of most dietary supplements. There is potential for the
development of antimicrobial drugs utilizing EOs, and understanding how they affect
animal cells compared to the cells of microbes is crucial to developing these types of
pharmaceuticals. Limited clinical trials have been performed using EOs and oil-based
products, however in vitro cytotoxicity assays are more common. These preliminary
results indicate that there are few risks of EO treatments posing significant risks to human
or animal cells.
The bacterium S. moorei, which is associated with halitosis in humans, was found
to be susceptible to cinnamon bark oil at a concentration of 0.039% and the oil was found
to significantly decrease biofilm formation in this species. In the same experiment, the
toxicity of cinnamon bark oil to oral keratinocytes was assessed in vitro and no
significant decrease in keratinocyte viability was detected at the same concentration. In
fact, a decrease in keratinocyte viability was only detected once the concentration of
CBO applied was above three times the MIC for S. moorei (LeBel et al., 2017). The
essential oil components carvacrol, cinnamaldehyde, and thymol were all found to be less
cytotoxic to human macrophages and keratinocytes than the widely used antiseptic
chlorhexidine (García-Salinas et al., 2018).
In one of the few published experiments using essential oils in an animal model,
wounds infected with methicillin-resistant S. aureus (MRSA) in mice were treated with
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dill essential oil. Manzuoerh et al. (2019) found that the oil treatment was more effective
at treating infection than the antibiotic cream containing mupirocin. Additionally, the dill
oil ointment reduced the inflammatory phase of the infection and led to faster wound
healing by promoting angiogenesis and collagen biosynthesis.
PHYTO-MAST® (Dr. K’s Formula, Graham, NC) is an intramammary treatment
for clinical mastitis in cattle that is intended for use in organic systems because it does
not contain traditional antibiotics. PHYTO-MAST® contains essential oils derived from
thyme, wintergreen, Chinese liquorice, and ginseng. Intramammary application of the
product was deemed safe for cattle, with no evidence of an inflammatory response to the
product and rapid disappearance of thymol markers in both the tissue and in milk
following treatment (McPhee at al., 2011). Taken together, these results indicated that
essential-oil based products have the potential to be safe for topical and intramammary
use in humans and animals, and we believe that further work toward the development of
pharmaceuticals containing essential oils is merited.
Applications for This Work
Given the range of antimicrobial activities of various plant essential oils and their
relatively low toxicity to animals, I believe that there are a number of applications for
these compounds in the areas of medicine, antiseptic products, and food preservation.
Based on our research, I believe that replacing some antibiotics and antiseptics with EObased products could slow the development of antimicrobial resistance in community,
clinical, and agricultural settings. Here, I outline a few potential applications for essential
oil products that I believe have the highest potential for success based off currently
available information.
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First, the use of topical medications containing essential oils may aid in treating
superficial wounds or preventing colonization of wounds or burns by microbes. This is
supported by the bacteriostatic, bactericidal, and anti-biofilm activities of many plant oils
against bacterial species that commonly infect wounds including, but not limited to,
Staphylococcus spp., Streptococcus spp., Pseudomonas aeruginosa, and Enterococci.
Essential oils have demonstrated generally non-toxic behavior toward eukaryotic cell
types associated with skin abrasions (García-Salinas et al., 2018) and may even aid in
promoting activities related to wound healing in some cases (Manzuoerh et al., 2019).
Since the oils are not very water soluble, oral administration of a drug could present
significant challenges. Topical administration is a promising application that circumvents
this challenge. Similarly, oral care products such as a medicated toothpaste or mouth
rinse could provide a safe and effective treatment for bacterial colonization.
Along the same lines, there is a potential application in dairy animals for the use
of essential oils in teat dips. Currently, there are two commercially available products
intended for intramammary use in dairy cattle (Cinnatube and Phytomast). These
products are not FDA approved for treatment of mastitis and did not show a significant
difference in their effectiveness at curing infection compared to a negative control
(Mullen et al., 2014). Cinnatube is marketed as an intramammary teat sealant device and
is indicated as an aid in the prevention of new intramammary infection throughout the dry
period by providing a physical, malleable, barrier in the teat canal (Zelpharma,
https://cinnatube.com/label). There is some evidence that these products could be
effective at helping to prevent new infections. One small study enrolling eight cows per
treatment group found no difference in new intramammary infections (IMI) over a six-
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week period between cows receiving an essential oil-based post-milking teat dip and a
conventional treatment of chlorhexidine and iodine (Marcelo et al., 2020). With only 336
cow days at risk for new IMI in each treatment group and an apparent low prevalence of
infection in the study herd, the power to detect a difference between groups may have
been limited. Based on these results, further work developing and testing EO-based teat
dips is merited, and future studies should incorporate a prior power calculations during
study design.
Lastly, there is some interest in incorporating essential oils or their components in
food preservation in order to avoid the use of synthetic preservatives, salt or sugar, all of
which are becoming increasingly unappealing to consumers in recent years. In vitro
results have shown that many essential oils are capable of inhibiting growth of foodborne
pathogens, however more research must be performed regarding the effect on the food
products and the consumers themselves before EOs can actually make their way into our
food (Hyldgaard et al., 2012).
Conclusion
My experiments support the hypothesis that penicillin and cinnamon bark oil
apply unique selective pressures to S. aureus in vitro. Based on our results, resistance to
penicillin occurs more rapidly and to a greater extent than resistance to cinnamon bark oil
after prolonged exposure to the antimicrobials at sub MIC levels. Therefore, I propose
that replacing some antibiotics or antiseptics with essential oil products, primarily in
clinical and agricultural settings, will help to decrease selection pressure for antibiotic
and multi-drug resistant bacteria, thereby reducing the number of deaths and high
healthcare costs associated with these types of infections. Based on available information,
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I suggest that the most promising applications for essential oil products are topical
pharmaceuticals and antiseptic teat dips for dairy animals. In order to identify the
mechanisms of action of essential oils and the potential mechanisms of resistance to EOs,
whole-genome sequencing of isolates with increased tolerance to any of these compounds
is encouraged. Additionally, further serial exposure experiments utilizing different oils
and oil components is recommended. Overall, the broad-spectrum antimicrobial activity
of many plant essential oils, combined with their low toxicity to eukaryotic cells and
decreased selective pressure compared to traditional antibiotics, makes them excellent
candidates for antimicrobial drugs and antiseptic products.
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